Low prevalence of meticillin-resistant Staphylococcus aureus carriage at hospital admission: Implications for risk-factor-based vs universal screening

Journal of Hospital Infection

Volumn 83, Issue 2, 2013, Pages 114-121

  Otter, J A ^a   Herdman, M T ^b   Williams, B ^b   Tosas, O ^a   Edgeworth, J D ^a   French, G L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Admission; CA MRSA; Carriage; Colonization; MRSA; Prevalence; Screen; Universal screening

Indexed keywords

ACCIDENT; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM DETECTION; CHILD; CONTROLLED STUDY; EMERGENCY; FEMALE; GENOTYPE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; NEWBORN; OBSERVATIONAL STUDY; PATIENT REFERRAL; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD; TERTIARY HEALTH CARE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TESTS, ROUTINE; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; LONDON; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PATIENT ADMISSION; PREVALENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84873099366     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.10.008     Document Type: Article

References (28)

1. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998, 339:520-532.
2. Dancer S.J. Considering the introduction of universal MRSA screening. J Hosp Infect 2008, 69:315-320.
3. Coia J.E., Duckworth G.J., Edwards D.I., et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006, 63:1-44.
4. Cookson B., Bonten M.J., Mackenzie F.M., Skov R.L., Verbrugh H.A., Tacconelli E. Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. Int J Antimicrob Agents 2011, 37:195-201.
5. Weber S.G., Huang S.S., Oriola S., et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Am J Infect Control 2007, 35:73-85.
6. Harbarth S., Sax H., Fankhauser-Rodriguez C., Schrenzel J., Agostinho A., Pittet D. Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med 2006, 119:275. e15-23.
7. Zetola N., Francis J.S., Nuermberger E.L., Bishai W.R. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005, 5:275-286.
8. Otter J.A., French G.L. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010, 10:227-239.
9. Otter J.A., French G.L. Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition. J Hosp Infect 2012, 81:143-148.
10. Batra R., Eziefula A.C., Wyncoll D., Edgeworth J. Throat and rectal swabs may have an important role in MRSA screening of critically ill patients. Intensive Care Med 2008, 34:1703-1706.
11. Otter J.A., French G.L. The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000-2006. Clin Microbiol Infect 2008, 14:670-676.
12. Milheirico C., Oliveira D.C., de Lencastre H. Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob Agents Chemother 2007, 51:3374-3377.
13. Otter J.A., French G.L. Utility of antimicrobial susceptibility-based algorithms for the presumptive identification of genotypically-defined community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital. Eur J Clin Microbiol Infect Dis 2011, 30:459-463.
14. Boakes E., Kearns A.M., Ganner M., et al. Molecular diversity within clonal complex 22 methicillin-resistant Staphylococcus aureus encoding Panton-Valentine leukocidin in England and Wales. Clin Microbiol Infect 2011, 17:140-145.
15. Reilly J.S., Stewart S., Christie P., et al. Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study. J Hosp Infect 2012, 80:31-35.
16. Collins J., Raza M., Ford M., Hall L., Brydon S., Gould F.K. Review of a three-year meticillin-resistant Staphylococcus aureus screening programme. J Hosp Infect 2011, 78:81-85.
17. van Velzen E.V., Reilly J.S., Kavanagh K., et al. A retrospective cohort study into acquisition of MRSA and associated risk factors after implementation of universal screening in Scottish hospitals. Infect Control Hosp Epidemiol 2011, 32:889-896.
18. Jeyaratnam D., Whitty C.J., Phillips K., et al. Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 2008, 336:927-930.
19. Gopal Rao G., Michalczyk P., Nayeem N., Walker G., Wigmore L. Prevalence and risk factors for meticillin-resistant Staphylococcus aureus in adult emergency admissions - a case for screening all patients?. J Hosp Infect 2007, 66:15-21.
20. Harbarth S., Fankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149-1157.
21. Edgeworth J.D. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. J Antimicrob Chemother 2011, 66(Suppl. 2):ii41-ii47.
22. Health Protection Scotland, National Services Scotland, NHS Scotland MRSA Screening Pathfinder Programme; Final Report. Executive Summary 2011. Health Protection Scotland [Report].
23. Cooper B.S., Medley G.F., Stone S.P., et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci USA 2004, 101:10223-10228.
24. Jacqui Reilly, Sally Stewart, Traiani Stari, et al. Health Protection Scotland, National Services Scotland, NHS Scotland MRSA Screening; Update Report on Pathfinder project 2011. Health Protection Scotland [Report].
25. Robotham J.V., Graves N., Cookson B.D., et al. Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation. BMJ 2011, 343:d5694.
26. Popovich K.J., Weinstein R.A., Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?. Clin Infect Dis 2008, 46:787-794.
27. Otter J.A., French G.L. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J Hosp Infect 2011, 79:189-193.
28. Yang E.S., Tan J., Eells S., Rieg G., Tagudar G., Miller L.G. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect 2009, 16:425-431.